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INTRODUCTION 
ZINC APPEARS to exert potent biological effects on a variety of cells. Zinc can act as a 
mitogen when added directly to lymphocyte cultures (Ri~hl et al., 1971; Berger and Skin- 
ner, 1974). Zinc deficiency in animals has been associated with abnormal development of 
the thymus (Kroneman et al., 1975), the lymphoid system (Tanaka et al., 1978) and defec- 
tive immune function (Iwata et al., 1979; Fraker et al., 1977; Fernandes et al., 1979). 
Pharmacological doses of zinc suppress the sickling phenomenon in sickle cell anemia 
(Arnone and Williams, 1977). The mechanism of action of zinc, however, is not well 
understood. In the present paper I describe the effects of zinc on concanavalin A (con 
A)-induced capping in relation to age. The experimental evidence suggests that zinc might 
act by influencing the microfilament function and that alteration in microfilament func- 
tion might be an important aspect of the aging phenomenon. 
Interaction of ligands with surface receptors of lymphocytes leads to rapid changes in 
the surface membrane and polarization of the receptors leading to what is termed "cap" 
formation. Treatment of human peripheral blood lymphocytes (PBL) with fluoresceinated 
concanavalin A (F-con A) at 37°C induces cap formation in about 10°70 of the labeled 
lymphocytes. Cap formation can be altered by cytoskeletal modulating agents such as col- 
chicine (de Petris, 1974; Albertini et al., 1977) and cytochalasin B (CB) (de Petris, 1974; 
Yahara and Edelman, 1973). It has been proposed that the cell surface receptors are an- 
chored to microtubules and microfilaments and disruption of these elements lead to 
alterations in surface receptor mobility (Yahara and Edelman, 1973). 
Our previous work indicated that zinc modulates lectin-induced mitogenic responses of 
human PBL in an age-dependent fashion (Rao et al., 1979). Further, we presented evi- 
dence indicating that the effect of zinc might be exerted through CB sensitive structures 
(Rao and Schwartz, 1980). This observation prompted me to study the effect of zinc on 
con A-induced cap formation of lymphocytes obtained from young and old individuals. 
The experimental evidence presented in this paper indicates that zinc has a differential ef- 
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fect on con A-induced lymphocyte capping, analogous to its effect on mitogenic responses 
(Rao et al., 1979) 
M A T E R I A L S  AND M E T H O D S  
Donors 
Blood from young and aged healthy volunteer donors was freshly obtained from a peripheral vein. All donors 
gave informed consent consistent with the policies of  The University of  Michigan and the Department of  Health 
and H u m a n  Services. The aging population ranged from 65-84 years; the young adult population ranged from 
22-35 years. 
Isolation of mononuclear cells 
Mononuclear  cells were prepared from fresh heparinized blood (20U/ml) by the Ficoll-Hypaque density 
gradient technique. The cells were washed three t imes with Ca*" and Mg ÷÷ free Hanks '  balanced salt solution 
(HBSS, Grand Island Biological Co. ,  Grand Island, NY) and resuspended in RPMI-1640 medium (Grand Island 
Biological Co.). 
Drugs 
CB and colchicine were obtained from Sigma Chemical Co.,  St. Louis, MO. Colchicine solution was prepared 
in water. CB was dissolved in 95°7o ethanol to a concentration of  2 x 10 -a M and appropriate dilutions were 
made in HBSS. Zncl~ was obtained from Fisher Scientific Co.,  NJ. F-Con A was obtained from Calbiochem- 
Behring Corp. ,  LaJolla, CA. 
Capping experiments 
Mononuclear  cells were suspended at a concentration of  4-6 x 106/ml, and 0.5 ml was used for each experi- 
ment.  Drugs were added to the cells and the suspension was incubated at 37°C for 30 min with continuous rota- 
tion. Then F-con A was added to give a final concentration of  20 #g/ml  and incubated for another  30 rain. At the 
end of  incubation the cells were fixed with 0.5 ml of  2°70 paraformaldehyde for 10 min, washed twice with HBSS 
and the number  of  caps formed were enumerated under fluorescent microscopy by counting 100 cells. Caps were 
defined as cells showing less than 1/3 surface fluorescence. 
RESULTS 
Cap formation with fluoresceinated con A 
Fig. 1 illustrates the number  of  caps formed when the cells were treated with F-con A 
alone. The number  of  caps formed varied f rom 4 % - 1 6 %  and no difference could be 
detected in results obtained from cells f rom young and old donors (Student's t-test p = 
0.85). 
The monocyte content of  our cell suspension did not seem to affect our results since 
many  of  the monocytes are lost (perhaps due to adherence to plastic) during the process of  
incubation at 37°C. Further, monocytes have a tendency to clump and during enumera- 
tion of  capping under fluorescent microscopy clumped cells were omitted. In one experi- 
ment,  where monocyte contaminat ion was monitored with latex ingestion, few monocytes 
were detected at the time of  counting, and the results were similar to non-latex ingested 
specimens. Thus, although a mononuclear  cell preparat ion was used throughout these ex- 
periments the differences noted could be attributed mainly to lymphocytes. 
Effect o f  colchicine on con A-induced capping 
Preincubation with colchicine (10 -5 M, final concentration) increased the number of  
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FIo. 1. Con A-induced capping of human peripheral 
blood lymphocytes. Lymphocytes were treated with 20 
#g/ml (final concentration) of F-Con A and the number 
of caps formed were enumerated under fluorescent 
microscopy. Age of the young individuals was between 
22-35 years and old individuals 65-84 years. In this and 
all subsequent figures each point represents data derived 
from a different cell donor. 
caps formed in both groups (Fig. 2). The number of  caps formed in the young population 
was 47 ± 15 (mean 4- 1 SD), whereas in the old group it was 57 ± 9 (mean ± 1 SD). 
Statistical analysis by the Mann-Whitney used statistic test gave a value of  62.5 which was 
significant at p = 0.024. 
Effect of  colchicine plus zinc on con A-induced capping 
Preincubation with zinc alone, followed by F-con A treatment failed to bring about a 
significant change in the number  of  caps formed as compared to treatment with F-con A 
alone (F-con A - 6°70, zinc and F-con A -- 507o). However,  when mononuclear  cells were 
incubated with both colchicine (10 s M)  and zinc (10 -4 M )  together for 30 min followed by 
F-con A treatment and compared with colchicine pre-treatment alone, dramatic dif- 
ference was observed in the number  of  caps formed between the two groups (Fig. 3). Ad- 
dition of  zinc caused further enhancement of  the number  of  caps formed in the younger 
age group as compared to the effect of  colchicine alone, whereas in the aged population 
the number  of  caps decreased when compared to colchicine alone. The difference was 
highly significant (p  = 0.0002) using the Wilcoxan Rank-Sum test. 
Effect of  colchicine plus cytochalasin B on con A-induced capping 
The effect of  CB on con A-induced capping was studied at two concentrations 10 -6 M 
and 10 .7 M (Fig. 4 a,b). At a concentration 10 .4 M of  CB (Fig. 4a) the number of  caps 
formed decreased in both groups as compared to pretreatment with colchicine alone. At 
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FIG. 2, Effect of  colchicine on Con A-induced 
capping. Lymphocytes  were pretreated with col- 
chicine (10 -~ M, final concentration) for 30 min 
and then incubated with F-con A for an addi- 
tional 30 min. 
10 -7 M the effect was variable in both groups (Fig. 4b). Statistical analysis revealed no dif- 
ference between the groups at these two concentrations of  CB. 
DISCUSSION 
The experimental results show that treatment of human PBL with con A alone does not 
show any difference in the capping phenomenon between the young and aged population. 
This is in contrast to a recent report in which a difference in capping was noted between 
young and old individuals using con A alone (Naeim and Walford, 1980). This discrepancy 
could be due to the difference in the age of  the older group which ranged from 80 to 98 in 
their study and 65 to 84 in my study. However, use of colchicine and zinc elicited signifi- 
cant differences between the young and old population in the present evaluation. 
I offer the following interpretation for the observations described in this paper. It has 
been proposed that cell surface receptors are anchored to microtubules and micro- 
filaments, and these structures have been attributed interrelated but opposite roles in 
maintaining the distribution and the mobility of  surface receptors (Poste et al., 1975 a,b). 
The inability of con A alone to demonstrate any difference between the two groups 
studied may be attributed to the anchoring effect of microtubules which might mask the 
differences in microfilament function. Once the microtubules are disrupted by colchicine, 
microfilaments, now unopposed, can bring about enhancement in capping and whatever 
differences exist between the microfilaments of  lymphocytes from young and old persons 
become apparent. In these experiments when colchicine alone was used the differences 
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FIo. 3. Effect of  colchicine plus zinc on con 
A-induced capping. Lymphocytes were pretreated 
with colchicine (10 .5 M, final concentration) plus 
zinc (10 .4 M, final concentration) for 30 min and 
then incubated with F-con A for an additional 30 
min. The caps formed with colchicine plus zinc 
t reatment  were compared to colchicine treatment  
alone and the difference in the number  of  caps, 
per 100 cells counted, was plotted. 
were significant at p = 0.024. But when zinc was added in addition to colchicine the dif- 
ference was even more dramatic (p = 0.0002). Our previous observation that zinc 
modulates mitogenic responses by affecting CB sensitive structures (Rao and Schwartz, 
1980) is consistent with the present finding that zinc is involved in modulating the capping 
phenomenon-another  microfilament dependent function. 
CB completely inhibits capping at high concentrations. For this reason the effect of CB 
on capping was tested at very low concentrations of CB; unlike zinc, CB does not show 
any age-dependent effects. This suggests that although both these agents act on microfila- 
ments they might exert their action at different sites among the steps involved in micro- 
filament formation or function. CB has been shown to inhibit actin polymerization by 
blocking filament elongation (Lin et al., 1980). It is conceivable that zinc might be acting 
on some other molecule which might also have a role in microfilament formation or func- 
tion. Calmodulin, a calcium regulating protein, is found in close association with micro- 
filaments (Welsh et al., 1978). It was proposed that the effect of zinc on cellular function 
might be mediated through its inhibitory action on calmodulin (Brewer et al., 1979). Tri- 
fluoperazine, a known inhibitor of calmodulin (Levin and Weiss, 1977), can also in- 
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FIG. 4. Effect of colchicine plus cytochalasin B on con A-induced capping. Lymphocytes were preincubated with 
colchicine (10 .5 M, final concentration) plus cytochalasin B (10 -6 M, Fig. 4a; 10-' M, Fig. 4b). Experimental pro- 
tocol was similar to that described in Fig. 3. 
fluence con A-induced capping (Bourguignon and Balazovich, 1980). Thus, the observa- 
tions reported in this paper might be pointing to an important area governing cell function 
which might be relevant to the study of the aging process. Experimental approaches to the 
study of actin polymerization and calmodulin function in relation to age might yield fruit- 
ful results in our quest to understand the molecular mechanism of senescence. 
SUMMARY 
Con A-induced capping of lymphocytes is altered by a number of cytoskeletal modulat- 
ing agents. Zinc, in the presence of colchicine, demonstrated an age-dependent differential 
effect on con A-induced capping of human peripheral blood lymphocytes. In general, zinc 
enhanced capping of lymphocytes from young individuals and suppressed from those of 
old individuals. 
The effect of zinc on the cap formation adds further support to the evidence that zinc 
might be acting on the microfilaments. However, cytochalasin B, another microfilament 
modulating agent, does not show a differential effect similar to zinc. This suggests that 
zinc might modify microfilament formation or function in a manner different from cyto- 
chalasin B. The proposal that the effects of zinc might be due to its action on calmodulin 
suggests that calmodulin, the calcium regulating protein, may have a role in the physio- 
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log ica l  p rocesses  a s s o c i a t e d  wi th  ag ing .  F u r t h e r  s tudies  in this  a r e a  m i g h t  y ie ld  f ru i t f u l  
resu l t s  in o u r  u n d e r s t a n d i n g  o f  t he  m o l e c u l a r  m e c h a n i s m  o f  senescence .  
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